News

Eli Lilly and Company and Banner Alzheimer's Institute announced a strategic research collaboration as part of the planned Phase 3, randomized, placebo-controlled study evaluating…
Read More...

GentiBio, Inc., an emerging biotherapeutics company developing best-in-class engineered regulatory T cells programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic…
Read More...

Thermo Fisher Scientific Inc. the world leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing…
Read More...

Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced it has entered into a definitive agreement to acquire LakePharma Inc., a…
Read More...

MediPharm Labs Corp. a pharmaceutical company specialized in research-driven development and manufacturing of cannabis API and finished products, is pleased to announce it has received…
Read More...

Medable Inc., the leading cloud platform for patient-centered drug development, announced the first stage of its European expansion plans with a new EMEA headquarters in Dublin. The…
Read More...

Eli Lilly and Company announced the acquisition of Protomer Technologies ("Protomer"), a private biotech company. Protomer's proprietary peptide- and protein-engineering platform is…
Read More...

Kriya Therapeutics, Inc., a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy, announced the closing of a $100 Million Series B financing…
Read More...

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Dynakin, a contract research…
Read More...

Ionis Pharmaceuticals, Inc. announced that it has entered into an exclusive licensing agreement with Bicycle Therapeutics plc to increase the delivery capabilities of Ionis' advanced …
Read More...

Biogen Inc. and InnoCare Pharma Limited announced that they have entered into a license and collaboration agreement for orelabrutinib, an oral small molecule Bruton’s tyrosine kinase…
Read More...

FlowMetric Life Sciences Inc., a globally recognized life sciences company, announces the launch of VaxEffect COVID-19 Vaccine Immune Response Test, a unique and powerful platform…
Read More...

Prothena Corporation plc and Novo Nordisk A/S  announced that the companies have entered into a definitive purchase agreement under which Novo Nordisk has acquired Prothena’s clinical…
Read More...

Prime Medicine, a company delivering on the promise of Prime Editing to provide lifelong cures to patients, today announced its launch with $315 million in financing. The financing…
Read More...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health…
Read More...

SPI Pharma introduces UltraBurst, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristics — dissolution time. It is an innovative excipient…
Read More...

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in …
Read More...

NRx Pharmaceuticals a clinical stage pharmaceutical company announced that it has signed a Memorandum Of Understanding with the Government of Israel to license exclusive worldwide…
Read More...

I-Mab a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced the signing of two new collaborations with…
Read More...

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration…
Read More...